Jianwen YU The First Affiliated Hospital of Sun Yat-sen UniversityChina

M.D., Ph.D., graduated from Sun Yat-sen University in Guangzhou, China, and currently focuses on the development of new therapeutic drugs for lupus nephritis and new technologies for peritoneal dialysis.

1 APRIL 2023

Time Session
14:15
15:15
Late Breaking Clinical Trials Session
Liz Lightstone Chairperson Imperial College London and Hammersmith HospitalUnited Kingdom
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • STOP-ACEi Study
    Sunil Bhandari Speaker Hull & East Yorkshire Hospitals NHS Trust United Kingdom
  • Q and A
  • DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
    Natalie Staplin Free Communication University of OxfordUnited Kingdom
  • Q and A
  • SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
    Muh Geot Wong Speaker University of SydneyAustralia
  • Q and A
  • RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    Jianwen YU Free Communication The First Affiliated Hospital of Sun Yat-sen UniversityChina
  • Q and A
Plenary Halls 2 & 3